1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research & Forecasting
2.1. Research Methodology
2.1.1. Research Process
2.1.2. Research Framework
2.1.3. Research Reliability & Validity
2.1.4. Research Assumptions
2.2. Forecasting Methodology
2.3. Research Outcome
2.3.1. 360iResearch Competitive Strategic Window
2.3.1.1. Leverage Zone
2.3.1.2. Vantage Zone
2.3.1.3. Speculative Zone
2.3.1.4. Bottleneck Zone
2.3.2. 360iResearch FPNV Positioning Matrix
2.3.2.1. 360iResearch Quadrants
2.3.2.1.1. Forefront
2.3.2.1.2. Pathfinders
2.3.2.1.3. Niche
2.3.2.1.4. Vital
2.3.2.2. Business Strategy
2.3.2.2.1. Business Growth
2.3.2.2.2. Industry Coverage
2.3.2.2.3. Financial Viability
2.3.2.2.4. Channel Support
2.3.2.3. Product Satisfaction
2.3.2.3.1. Value for Money
2.3.2.3.2. Ease of Use
2.3.2.3.3. Product Features
2.3.2.3.4. Customer Support
3. Executive Summary
3.1. Outlook in the Direct-to-Consumer Genetic Testing Market
3.2. Opportunities in the Direct-to-Consumer Genetic Testing Market
4. Premium Insight
4.1. Market Connectivity
4.2. Market Dynamics
4.2.1. Drivers
4.2.1.1. Paradigm shift among consumers seeking greater control over their own healthcare
4.2.1.2. Rising awareness about genome testing and risk of genetic diseases
4.2.1.3. High aging population coupled with growing prevalence of chronic disorders
4.2.1.4. Increased inquisitiveness about the assessment of lineage and ancestry
4.2.2. Restraints
4.2.2.1. Related scientific, technical, and clinical issues
4.2.2.2. First amendment issues of honesty, fidelity to facts, and truth-in-advertising
4.2.3. Opportunities
4.2.3.1. Next-generation sequencing and bio-chip for present and future genetic diagnosis
4.2.3.2. Development of online applications to serve customer needs
4.2.4. Challenges
4.2.4.1. Complexity of test result interpretation
4.2.4.2. Lack of adequate physician knowledge about genetics and potential for genetic discrimination
4.3. Porter's Five Forces Analysis
4.3.1. Threat of New Entrants
4.3.2. Threat of Substitutes
4.3.3. Bargaining Power of Customers
4.3.4. Bargaining Power of Suppliers
4.3.5. Industry Rivalry
4.4. Industry Trends
4.4.1. Pricing Analysis
4.4.1.1. Disease Risk and Health
4.4.1.2. Ancestry or Genealogy
4.4.1.3. Kinship
4.4.1.4. Lifestyle
4.4.2. Regulatory Framework, By Geography
4.4.3. State of Import & Export of DNA Extracts for Shipping, By Geography
4.4.4. DNA Sequences Market Prospects for Genome Testing
5. Global Direct-to-Consumer Genetic Testing Market, by Type
5.1. Overview
5.2. Market Sizing & Forecasting
5.3. Mitochondrial DNA Testing
5.4. Single Nucleotide Polymorphism Testing
5.5. Y Chromosome Testing
6. Global Direct-to-Consumer Genetic Testing Market, by Channel
6.1. Overview
6.2. Market Sizing & Forecasting
6.3. Offline
6.4. Online
7. Global Direct-to-Consumer Genetic Testing Market, by Result
7.1. Overview
7.2. Market Sizing & Forecasting
7.3. Ancestry & Ethnicity
7.4. Cancer Screening
7.4.1. Hereditary Cancer
7.4.1.1. Blood Cancer
7.4.1.2. Breast Cancer
7.4.1.3. Ovarian Cancer
7.4.2. Sporadic Cancer
7.5. Genetic Disease Carrier Status
7.6. New Baby Screening
7.7. Traits
7.8. Wellness
8. Global Direct-to-Consumer Genetic Testing Market, by Geography
8.1. Overview
8.2. Market Sizing & Forecasting
8.3. Americas
8.3.1. Overview
8.3.2. Market Sizing & Forecasting
8.3.3. Argentina
8.3.4. Brazil
8.3.5. Canada
8.3.6. Mexico
8.3.7. United States
8.4. Asia-Pacific
8.4.1. Overview
8.4.2. Market Sizing & Forecasting
8.4.3. Australia
8.4.4. China
8.4.5. India
8.4.6. Japan
8.5. Europe, Middle East & Africa
8.5.1. Overview
8.5.2. Market Sizing & Forecasting
8.5.3. France
8.5.4. Germany
8.5.5. Italy
8.5.6. Spain
8.5.7. United Kingdom
9. Competitive Landscape
9.1. 360iResearch FPNV Positioning Matrix for Global Direct-to-Consumer Genetic Testing Market
9.2. Market Vendor Ranking Analysis for Global Direct-to-Consumer Genetic Testing Market
9.3. Competitive News Feed Analysis for Global Direct-to-Consumer Genetic Testing Market
10. Company Usability Profiles
10.1. 23andMe, Inc.
10.1.1. Overview
10.1.2. Strategy
10.1.3. SWOT
10.2. AlphaBiolabs Ltd
10.2.1. Overview
10.2.2. Strategy
10.2.3. SWOT
10.3. Counsyl, Inc.
10.3.1. Overview
10.3.2. Strategy
10.3.3. SWOT
10.4. Eastern Biotech & Life Sciences FZ-LLC
10.4.1. Overview
10.4.2. Strategy
10.4.3. SWOT
10.5. EasyDNA
10.5.1. Overview
10.5.2. Strategy
10.5.3. SWOT
10.6. Gene By Gene Ltd.
10.7. International Bioscience Corp
10.8. Laboratory Corporation of America, Inc.
10.9. Medichecks.Com
10.10. Myriad Genetics, Inc.
10.11. Positive Biosciences, Ltd.
10.12. Quest Diagnostics Incorporated
10.13. Shuwen Biotech Co. Ltd.
10.14. Vitagene, Inc.
10.15. Xcode Life Sciences Pvt Ltd
11. Appendix
11.1. Discussion Guide
11.2. Top Reports
11.2.1. Global Crane Rental Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
11.2.2. Global Computer Vision Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
11.2.3. Global Payment Gateway Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
11.2.4. Global B2B Travel Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
11.2.5. Global Varicose Vein Treatment Devices Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
11.3. Author Details